Essential Paralogous Proteins as Potential Antibiotic Multitargets in Escherichia coli

• Published in: Microbiology spectrum 2022-12, Vol.10 (6), p.e0204322-e0204322
• Main Author: Hardy, Christine D
• Format: Article
• Language: English
• Subjects: Anti-Bacterial Agents - chemistry; antibiotic resistance; antibiotic targets; Antimicrobial Chemotherapy; Bacteria; DNA Topoisomerase IV; Drug Resistance, Bacterial - genetics; Escherichia coli; Escherichia coli Proteins - metabolism; Microbial Sensitivity Tests; multitargeting; Research Article
• ISSN: 2165-0497; 2165-0497
• DOI: 10.1128/spectrum.02043-22

Antimicrobial resistance threatens our current standards of care for the treatment and prevention of infectious disease. Antibiotics that have multiple targets have a lower propensity for the development of antibiotic resistance than those that have single targets and therefore represent an important tool in the fight against antimicrobial resistance. In this work, groups of essential paralogous proteins were identified in the important Gram-negative pathogen Escherichia coli that could represent novel targets for multitargeting antibiotics. These groups include targets from a broad range of essential macromolecular and biosynthetic pathways, including cell wall synthesis, membrane biogenesis, transcription, translation, DNA replication, fatty acid biosynthesis, and riboflavin and isoprenoid biosynthesis. Importantly, three groups of clinically validated antibiotic multitargets were identified using this method: the two subunits of the essential topoisomerases, DNA gyrase and topoisomerase IV, and one pair of penicillin-binding proteins. An additional eighteen protein groups represent potentially novel multitargets that could be explored in drug discovery efforts aimed at developing compounds having multiple targets in E. coli and other bacterial pathogens. Many types of bacteria have gained resistance to existing antibiotics used in medicine today. Therefore, new antibiotics with novel mechanisms must continue to be developed. One tool to prevent the development of antibiotic resistance is for a single drug to target multiple processes in a bacterium so that more than one change must arise for resistance to develop. The work described here provides a comprehensive search for proteins in the bacterium Escherichia coli that could be targets for such multitargeting antibiotics. Several groups of proteins that are already targets of clinically used antibiotics were identified, indicating that this approach can uncover clinically relevant antibiotic targets. In addition, eighteen currently unexploited groups of proteins were identified, representing new multitargets that could be explored in antibiotic research and development.